Filter
1808
Text search:
Food
and
Drug
Administration
Featured
Recommendations
198
New Publications
535
Language
Document type
No document type
1056
Guidelines
319
Studies & Reports
223
Manuals
95
Strategic & Response Plan
51
Training Material
24
Fact sheets
23
Situation Updates
8
Resource Platforms
3
Brochures
2
Infographics
2
Videos
2
Countries / Regions
India
106
Ethiopia
69
Kenya
63
Nigeria
55
Tanzania
53
Global
49
Ghana
40
South Africa
40
Uganda
38
Liberia
36
Myanmar / Burma
35
Western and Central Europe
33
Sierra Leone
30
Philippines
29
Zambia
29
Rwanda
29
Nepal
28
Bangladesh
24
Latin America and the Carribbean
21
Malawi
17
Eastern Europe
16
Namibia
15
Africa
15
Indonesia
14
Lesotho
13
Zimbabwe
12
USA
11
Russia
11
Cambodia
10
South Sudan
9
Congo, Democratic Republic of
8
Germany
7
Syria
7
Mozambique
7
Botswana
7
West and Central Africa
7
Eswatini/ Swaziland
6
Colombia
6
Middle East and North Africa
6
Haiti
5
Thailand
5
Sudan
5
Brazil
5
Ukraine
5
South–East Asia Region
5
Eastern Europe and Central Asia
5
Cameroon
4
Jordan
4
East and Southern Africa
4
Venezuela
4
Laos
4
Somalia
3
Pakistan
3
Iraq
3
Papua New Guinea
3
Peru
3
Paraguay
3
Asia
3
Iran
3
Senegal
2
Morocco
2
Benin
2
Central African Republic
2
Argentina
2
Libya
2
Angola
2
Sri Lanka
2
Yemen
2
Western Pacific Region
2
Poland
2
Timor Leste/ East Timor
2
Tajikistan
2
Guinea
1
Burkina Faso
1
Mali
1
Guinea-Bissau
1
Saudi Arabia
1
Afghanistan
1
Lebanon
1
Turkey
1
China
1
Singapore
1
Switzerland
1
Hungary
1
El Salvador
1
Greece
1
Mexico
1
Bhutan
1
Palestine
1
Albania
1
Qatar
1
Lithuania
1
Georgia
1
North America
1
Turkmenistan
1
Denmark
1
Maldives
1
Tunisia
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
797
Clinical Guidelines
197
Public Health
77
Women & Child Health
72
Key Resources
58
Pharmacy & Technologies
26
Capacity Building
25
Toolboxes
TB
132
Mental Health
130
AMR
125
HIV
112
COVID-19
102
Pharmacy
87
NTDs
68
Caregiver
42
Ebola & Marburg
34
Rapid Response
29
NCDs
29
Malaria
28
Planetary Health
26
Refugee
25
Conflict
15
Specific Hazards
14
Global Health Education
14
Disability
12
Cholera
12
Zika
9
Natural Hazards
7
2.0 Rapid Response
7
Polio
5
Social Ethics
4
Health Financing Toolbox
3
3 March 2022
The WHO Therapeutics and COVID-19: living guideline contains the Organization’s most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. The latest version of this living guideline is available in pdf
...
The report provides a brief introduction to patents and licences and their effect on the market for antiretroviral (ARV) medicines. It gives an overview of the patent landscape with respect to a sel
...
PQM conducted an assessment of the medicine quality assurance and quality control systems in Rwanda during November 9-13, 2009. Medicine quality assurance remains to be developed in Rwanda: the country has neither a medicine regulatory authority (MR
...
Since 2000, concerted efforts by national programmes, supported by public–private partnerships, nongovernmental organizations, donors and academia under the auspices and coordination of the World
...
This bi-weekly brief details the latest developments in scientific knowledge and public health policy from around the world as well as updates to the COVID-19-related guidance from Africa CDC, WHO and
...
Morbidity and Mortality Weekly Report
Recommendations and Reports: July 7, 2006 / Vol. 55 / No. RR-9
Introduction
Chapter A.7
Division of Global Migration and Quarantine
April 16, 2012
Report of a WHO technical consultation meeting
Ouagadougou, Burkina Faso
This article was published on December 10, 2020, and updated on December 16, 2020, at NEJM.org. DOI: 10.1056/NEJMoa2034577
Report
A Project of the Joep Lange Institute July, 2018
This twelfth version of the WHO living guideline now contains 19 recommendations. This latest update provides updated recommendations for remdesivir, addresses the use of combination therapy with corticosteroids, interleukin-6 (IL-6) receptor blockers and
...
International Journal of Basic & Clinical Pharmacology 5(6):2290-2294
DOI: 10.18203/2319-2003.ijbcp20164081
Q3: For behavioural and psychological symptoms in people with dementia, do following drugs, when compared to placebo/comparator, produce benefits/harm in the specified outcomes?
A survival guide for clinicans.
3rd edition.
NSP Review
Engaging with South Africa’s National Strategic Plan for HIV, STIs and TB Edition 7 July – August 2013
A publication of the Treatment Action Campaign and SECTION27
GeneXpert: An
...